KGF polypeptide compositions

Details for Australian Patent Application No. 2002326742 (hide)

International Classifications

Event Publications

23 January 2003 Complete Application Filed

Priority application(s): 60/313,881 21.08.01 US

29 May 2003 Application Open to Public Inspection

Published as AU-B-2002326742

9 March 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

15 June 2006 Section 223 Application Allowed

Chiron Corporation The time in which to request examination has been extended to 18 Mar 2006. Address for service in Australia - FB Rice & Co Level 23 200 Queen Street MELBOURNE VIC 3000

31 May 2007 Application Accepted

Published as AU-B-2002326742

6 December 2007 Standard Patent Sealed

27 November 2008 Alteration of Name

The name of the patentee has been altered to Novartis Vaccines and Diagnostics, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.